- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/68 - One oxygen atom attached in position 4
Patent holdings for IPC class C07D 213/68
Total number of patents in this class: 279
10-year publication summary
|
16
|
18
|
23
|
25
|
17
|
15
|
15
|
14
|
12
|
10
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Nippon Soda Co., Ltd. | 892 |
11 |
| ViiV Healthcare Company | 163 |
8 |
| Merck Patent GmbH | 5752 |
7 |
| Takeda Pharmaceutical Company Limited | 2721 |
7 |
| Astellas Pharma Inc. | 1057 |
7 |
| City of Hope | 1013 |
7 |
| Bristol-myers Squibb Company | 4826 |
6 |
| Glaxo Group Limited | 4145 |
5 |
| Vertex Pharmaceuticals Incorporated | 1630 |
5 |
| Kotobuki Pharmaceutical Co., Ltd. | 37 |
5 |
| Rutgers, The State University of New Jersey | 1934 |
5 |
| The Regents of the University of California | 20303 |
4 |
| Janssen Pharmaceutica N.V. | 3358 |
4 |
| Japan Science and Technology Agency | 1274 |
4 |
| The Research Foundation for The State University of New York | 1667 |
4 |
| Lighthouse Pharmaceuticals, Inc. | 11 |
4 |
| Syngenta Crop Protection AG | 6259 |
3 |
| The Johns Hopkins University | 5756 |
3 |
| The General Hospital Corporation | 4801 |
3 |
| Abbvie Inc. | 1817 |
3 |
| Other owners | 174 |